Valeant Pharmaceuticals

Valeant reaches Tentative Deal to Buy Provenge from Dendreon

Valeant reaches Tentative Deal to Buy Provenge from Dendreon

On Thursday, Quebec-based Valeant Pharmaceuticals International Inc. announced that it has entered into a stalking-horse agreement with Dendreon Corp. to buy its prostate- cancer drug Provenge and other assets for $296 million in cash.

As per the tentative deal, Valeant is the preferred bidder. If the company's bid does not win the auction then it would receive breakup fee and reimbursed expenses. Valeant also said that a bankruptcy court would be required to approve Valeant's stalking-horse bid and the sale.

Location: 

Childhood Eczema could persist in Adulthood as well

Childhood Eczema could persist in Adulthood as well

Childhood eczema could continue till adulthood for certain individuals and could even remain a life-long condition in certain cases contrary to common belief that it clears up by adolescence. Study lead Dr. David Margolis at the University of Pennsylvania Perelman School of Medicine said that 80 percent of the childhood eczema patients had the condition till age 26.

News: 

Popular Stories

Harley-Davidson to turn 8 Dyna motorbikes into new Softail bikes

Betting big on cruisers, the luxury motorcycle... Read More

Uber’s net loss declines as ride bookings grow

Uber Technologies reported lower loss by nearly 9... Read More

Samsung Galaxy Note 8 facing challenges on multiple fronts

The Samsung Galaxy Note 8 is facing an increasingly... Read More

Leaked reports reveal more about new BMW M5

Luxury carmaker BMW’s next-generation M5 car will... Read More

Tesla announces risky new approach to customer service

During the past few years, Tesla was slammed by a... Read More